PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

PMCB current pps and position:

"...a large discount to potential value – with potential value rooted in what we see as an inflection point for Pharmacyte. Unfortunately, we don’t know when this inflection point will come. Management has sort of gone out of its way to make sure we have no idea, which is a bit frustrating, but in some ways justifiable (think NDA's), but the thesis still stands – when it hits, we’re going to see some immediate upside in Pharmacyte’s market capitalization.